Keynatinib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Keynatinib, covering 2025-01-22 to 2025-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Keynatinib in Treated Patients With NSCLC and Brain Metastases [Phase 2]